Jeffrey Perl


Associate Scientist, Li Ka Shing Knowledge Institute


Dr. Jeffrey Perl received his MD from the University of Toronto in 2003, where he also completed his post-graduate training in both Internal Medicine and Nephrology in 2008. In 2010, he completed his Masters of Science in Clinical Epidemiology from The Harvard School of Public Health.

Dr. Perl is currently a Staff Nephrologist at St Michael’s Hospital in Toronto and an Assistant Professor in the Department of Medicine at the University of Toronto. He currently chairs the International Society of Nephrology’s Young Nephrologists Committee. His primary research interests and clinical practice focuses on improving the survival and quality of life for patients on peritoneal dialysis. Dr. Perl is a primary investigator in The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).

Recent Publications

  1. Hole, B, Hemmelgarn, B, Brown, E, Brown, M, McCulloch, MI, Zuniga, C et al.. Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world. Kidney Int Suppl (2011). 2020;10 (1):e86-e94. doi: 10.1016/j.kisu.2019.11.008. PubMed PMID:32149013 PubMed Central PMC7031687.
  2. Swanepoel, CR, McCulloch, MI, Abraham, G, Donner, JA, Alrukhaimi, MN, Blake, PG et al.. Challenges for sustainable end-stage kidney disease care in low-middle-income countries: the problem of the workforce. Kidney Int Suppl (2011). 2020;10 (1):e49-e54. doi: 10.1016/j.kisu.2019.11.007. PubMed PMID:32149008 PubMed Central PMC7031680.
  3. Glavinovic, T, Hurst, H, Hutchison, A, Johansson, L, Ruddock, N, Perl, J et al.. Prescribing high-quality peritoneal dialysis: Moving beyond urea clearance. Perit Dial Int. 2020; :896860819893571. doi: 10.1177/0896860819893571. PubMed PMID:32063213 .
  4. Wang, AY, Zhao, J, Bieber, B, Kanjanabuch, T, Wilkie, M, Marshall, MR et al.. International comparison of peritoneal dialysis prescriptions from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Perit Dial Int. 2020; :896860819895356. doi: 10.1177/0896860819895356. PubMed PMID:32063209 .
  5. Sahlawi, MA, Wilson, G, Stallard, B, Manera, KE, Tong, A, Pisoni, RL et al.. Peritoneal dialysis-associated peritonitis outcomes reported in trials and observational studies: A systematic review. Perit Dial Int. 2020;40 (2):132-140. doi: 10.1177/0896860819893810. PubMed PMID:32063197 .
  6. Gutman, T, Manera, KE, Baumgart, A, Johnson, DW, Wilkie, M, Boudville, N et al.. "Can I go to Glasgow?" Learnings from patient involvement at the 17th Congress of the International Society for Peritoneal Dialysis (ISPD). Perit Dial Int. 2020;40 (1):12-25. doi: 10.1177/0896860819880101. PubMed PMID:32063150 .
  7. Walsh, M, Merkel, PA, Peh, CA, Szpirt, WM, Puéchal, X, Fujimoto, S et al.. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. N. Engl. J. Med. 2020;382 (7):622-631. doi: 10.1056/NEJMoa1803537. PubMed PMID:32053298 .
  8. Manera, KE, Johnson, DW, Craig, JC, Shen, JI, Gutman, T, Cho, Y et al.. Establishing a Core Outcome Set for Peritoneal Dialysis: Report of the SONG-PD (Standardized Outcomes in Nephrology-Peritoneal Dialysis) Consensus Workshop. Am. J. Kidney Dis. 2020;75 (3):404-412. doi: 10.1053/j.ajkd.2019.09.017. PubMed PMID:31955922 .
  9. Perl, J, Fuller, DS, Bieber, BA, Boudville, N, Kanjanabuch, T, Ito, Y et al.. Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Am. J. Kidney Dis. 2020; :. doi: 10.1053/j.ajkd.2019.09.016. PubMed PMID:31932094 .
  10. Young, A, Beriault, D, Jung, B, Nikonova, A, Abosh, D, Lee, S et al.. DAMPAned Methotrexate: A Case Report and Review of the Management of Acute Methotrexate Toxicity. Can J Kidney Health Dis. 2019;6 :2054358119895078. doi: 10.1177/2054358119895078. PubMed PMID:31903191 PubMed Central PMC6926974.
Search PubMed

Affiliations & Other Activities

  • Nephrologist, Division of Nephrology, St. Michael’s Hospital
  • Assistant Professor of Medicine, University of Toronto
  • Chair, International Society of Nephrology’s Young Nephrologists Committee